Natalizumab: A Game Changer for MS?

Published: Feb 08, 2024

Natalizumab is a powerful drug for managing multiple sclerosis, but what makes it so effective, and what should patients watch out for?
Contents

How Natalizumab Works

Natalizumab is a monoclonal antibody that targets integrin molecules to prevent immune cells from entering the brain and spinal cord. By doing so, it reduces inflammation and nerve damage associated with MS, helping to decrease relapses and slow disease progression. This makes it an attractive option for patients with active relapsing forms of MS.

Administration and Dosage

Natalizumab is delivered via intravenous infusion every four weeks in a healthcare setting. This regular administration requires patient commitment and monitoring to ensure safety and efficacy. Extended interval dosing may be an option for some, potentially reducing certain risks while maintaining effectiveness.
Natalizumab is a monoclonal antibody used to manage multiple sclerosis by targeting integrin molecules to prevent immune cells from entering the brain and spinal cord.

Risks and Monitoring

A significant risk associated with natalizumab is PML, a rare brain infection. Patients must be regularly screened for JC virus antibodies, which can indicate increased risk of PML. Other side effects can include liver issues and various infections, necessitating ongoing surveillance and management.

Frequently Asked Questions

It is given by IV infusion every four weeks.

PML is a rare brain infection linked to natalizumab treatment.

Yes, extended intervals may reduce risks.

Side effects include infections and liver issues.

Wrapping Up

Natalizumab offers significant benefits for MS but requires careful monitoring for potential risks.
Consult Doctronic to see if natalizumab is the right choice for your MS treatment plan.

Related Articles

References

  1. Tyruko (natalizumab-sztn) prescribing information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761322s000lbl.pdf
  2. Zhovtis Ryerson L, Frohman TC, Foley J, et al. Extended interval dosing of natalizumab in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016; 87:885.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely